对T1膀癌替代阶段的当前情况进行系统审查
Xabier Pérez-Aizpurua1, Juan Ignacio Monzó-Gardiner1, Oana Beatrice Popescu2
1Department of Urology, Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain.
Urology
|October 10, 2024
概括
T1膀癌分期改善了结果的预测. 微观测量方法比组织测量技术更可复制,这表明标准化可以提高膀癌治疗.
科学领域:
- 尿瘤学 尿瘤学
- 癌症的分期 癌症的分期
- 病理学 病理学 病理学
背景情况:
- T1膀瘤表现出异质的行为和预后,需要精确的分期.
- 已经提出了各种替代阶段的方法,以更好地分层风险和指导治疗.
- 研究T1分期的诊断和预后价值对于改善瘤结果至关重要.
结论:
- 转移T1膀瘤提供了有价值的预后信息.
- 在临床实用性和可重复性方面,微观分期似乎更优越.
- 标准化和验证T1分期技术可以优化膀癌的管理.
相关概念视频
01:24Tissue Transplantation
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.